Practical Considerations in the Use of Lenalidomide Therapy for Myelodysplastic Syndromes

Cancer Control - United States
doi 10.1177/107327480601304s05
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications